首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1542882

全球一次性医院用品市场 - 2024-2031

Global Disposable Hospital Supplies Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

全球一次性医疗用品市场在 2023 年达到 4,784 亿美元，预计到 2031 年将达到 9,673 亿美元，2024-2031 年预测期间复合年增长率为 9.2%。

一次性医院用品是用于临时用于患者护理的一次性医疗产品，在初次使用后将被丢弃。这些物品对于维持卫生标准、预防感染以及保障医院环境内病患和医护人员的福祉至关重要。

一次性医院用品包括各种医疗用品，包括但不限于注射器、针头、手套、面罩、绷带、导管、输液器以及用于提供患者护理的多种其他消耗品。这些耗材涵盖广泛的应用，对于维持安全卫生的医疗环境至关重要。

一次性用品的主要目标是透过阻止病原体在患者和医疗保健提供者之间传播来减少交叉污染和医疗保健相关感染 (HAI) 的可能性。这些用品旨在透过最大限度地降低感染传播的风险来确保更安全的环境。

市场动态：

司机

外科手术数量不断增加

全球一次性医院用品市场的需求受到多种因素的推动。全球手术数量的增加是推动一次性医院用品市场扩张的关键因素。随着外科手术量的增加，一系列一次性物品的需求也随之增加，例如手术服、手套、手术单、餵食管以及治疗套件和托盘。

随着外科手术数量的增加，人们越来越重视感染预防。一次性用品在降低交叉污染和医院获得性感染 (HAI) 风险方面发挥着至关重要的作用，这些风险是手术环境中的重大问题。使用一次性物品可确保为每位患者提供无菌设备，从而提高患者安全。

此外，意识计划、研究、合作和产品发布等政府措施将推动该市场的成长。例如，2024年1月，印度药品监管局局长启动了国家单一窗口系统（NSWS），以简化医疗器材的监管流程。该倡议旨在创建一个综合平台，作为“真正的单一窗口系统”，使投资者能够在一个地方有效地管理所有必要的批准。

此外，2023 年 2 月，《柳叶刀》最近发表的评论强调了对医疗保健行业严重依赖一次性材料的严重担忧。这种依赖往往是出于恐惧和对效率的感知需求，而不是强有力的证据支持一次性用品优于彻底消毒的可重复使用的选择。

同样，2024 年 5 月，化学和肥料部製药部门与印度工业联合会 (CII) 合作发起了 MEDITECH STACKATHON。这项开创性的倡议旨在透过对选定的医疗设备进行全面的价值链分析，促进印度蓬勃发展的医疗科技产业的变革。

Stackathon将重点放在癌症治疗、影像、重症监护、辅助医疗器材、身体植入、手术器械、医院设备、消耗品和一次性用品以及IVD仪器和试剂等八个特定组别。

限制

一次性产品产生的废物增加、一次性医疗用品报销不足、严格的监管框架以及环境问题等因素预计将阻碍市场的发展。

细分市场分析

全球一次性医院用品市场根据产品类型、应用、最终用户和地区进行细分。

诊断供应商细分市场约占全球一次性医院用品市场份额的52.3%

预计诊断供应商细分市场将在预测期内占据最大的市场份额。诊断用品包括在医疗保健环境中执行诊断测试和监测的各种必需物品。这些用品对于准确评估患者健康状况和告知治疗选择至关重要。

诊断供应商包括测试套件、诊断成像供应商、试剂、医疗设备等。测试套件是预先组装的套件，包含执行特定诊断测试所需的所有组件。它们可用于多种目的，包括血液检测、尿液检测和传染病检测。这些套件透过提供标准化材料和清晰的说明来简化诊断过程。

此外，行业投资以及产品发布和批准的主要参与者将推动该市场的成长。例如，2024 年 8 月，专注于永续发展和包容性的现代个人防护装备 (PPE) 品牌 AmorSui 宣布已成功筹集 350 万美元种子资金。这笔资金旨在支持该公司的使命，创造不仅有效、而且环保且价格实惠的个人防护装备。医疗用品行业严重依赖一次性产品，并且越来越面临寻求可持续替代品的压力。

此外，2024 年 1 月，Inspira Technologies 宣布打算为其 INSPIRA ART 医疗设备系列推出一次性血液氧合套件，目前该套件正在开发中。该套件旨在与各种生命维持机器相容，使该公司能够进入一次性灌注系统市场。推出该套件是 Inspira 更广泛愿景的一部分，即用先进的生命维持技术取代传统的机械呼吸器。

同样，2023 年 9 月，美敦力 (Medtronic plc) 宣布其新型一体式一次性 Simplera 连续血糖监测仪 (CGM) 已获得 CE 标誌批准。这种创新设备具有简单的两步骤插入过程，不需要过度胶带，使其用户友好。 Simplera CGM 旨在与 InPen 智慧胰岛素笔无缝协作，提供即时、个人化的剂量指导，以简化糖尿病管理。

市场地域占有率

北美约占全球一次性医院用品市场份额的44.7%

由于呼吸道合胞病毒（RSV）等传染病发病率不断上升，北美地区预计将在预测期内占据最大的市场份额，这是推动北美一次性医院用品需求的关键因素。 RSV 病例的增加，特别是在加拿大，导致对用于管理和预防这些感染的一次性产品的需求增加。

北美医疗保健支出的激增直接影响一次性医院用品的供应和可用性。随着该地区医院投资扩大服务和升级设施，一次性用品的采购量也随之增加，这些用品对于提供优质的病患照护和维持严格的感染控制方案至关重要。对医疗基础设施的投资增加是推动北美一次性医院用品市场成长的重要因素。

此外，大量关键参与者的存在、伙伴关係和协作等策略有助于推动该地区的市场成长。例如，2023 年 5 月，在美国，Indegene 宣布扩大与 ConTIPI Medical Ltd 的合作关係，ConTIPI Medical Ltd 是为患有各种骨盆底功能障碍的女性提供非手术和一次性解决方案的创新者。此次合作旨在向市场推出一种新设备，加强对患有骨盆器官脱垂 (POP) 的女性的支持。

同样，2021 年 2 月，美国医疗用品和个人防护用品供应商 Health Professional Resources (HPR) 宣布与南亚最大的服装和纺织品製造商 MAS Holdings 建立製造合作伙伴关係。此次合作将使HPR 能够为医疗保健行业推出一系列新的高性能PPE 产品，所有产品均由MAS Holdings 製造，该公司在16 个国家拥有53 个製造基地，是Nike 和Victoria's Secret 等全球领先品牌的长期策略伙伴。 HPR 系列将包括手术服、隔离服、医用手术服、可重复使用的口罩和其他个人防护装备。

此外，先进的医疗保健基础设施、关键参与者协议和产品批准有助于推动该市场的成长。例如，2022 年7 月，专门从事综合呼吸护理的美国家庭医疗设备领域领先公司Quipt Home Medical Corpa 宣布与Cardinal Health, Inc.（纽约证券交易所股票代码：）旗下子公司Cardinal Health at-Home 签署合同。根据该协议，Quipt 将销售一次性医疗用品，而 Cardinal Health 将在全国范围内供应和分销这些产品。

此外，2024年1月，法国诺和诺德旗下专门从事创新医疗器材设计和製造的子公司BIOCORP宣布已获得美国食品药物管理局（FDA）的510(k)上市许可独奏智慧。这款智慧医疗设备旨在与赛诺菲生产的 SoloStar 胰岛素笔连接。

Disposable hospital supplies are single-use medical products intended for temporary use in patient care, which are discarded after their initial application. These items are crucial for upholding hygiene standards, preventing infections, and safeguarding the well-being of both patients and healthcare workers within hospital environments.

Disposable hospital supplies encompass a diverse array of medical items, including but not limited to syringes, needles, gloves, face masks, bandages, catheters, infusion sets, and a multitude of other consumables utilized in the provision of patient care. These supplies cover a broad spectrum of applications and are essential for maintaining a safe and hygienic healthcare environment.

The main objective of disposable supplies is to reduce the likelihood of cross-contamination and healthcare-associated infections (HAIs) by stopping the spread of pathogens between patients and healthcare providers. These supplies are designed to ensure a safer environment by minimizing the risk of infection transmission.

Market Dynamics: Drivers

Rising number of surgical procedures

The demand for the global disposable hospital supplies market is driven by multiple factors. The growing number of surgeries conducted globally is a key factor propelling the expansion of the disposable hospital supplies market. As the volume of surgical procedures increases, so does the need for a range of disposable items such as surgical gowns, gloves, drapes, feeding tubes, and treatment sets and trays.

As the number of surgical procedures increases, there is an increased emphasis on infection prevention. Disposable supplies play a crucial role in reducing the risk of cross-contamination and hospital-acquired infections (HAIs), which are significant issues in surgical environments. Utilizing single-use items guarantees that every patient is provided with sterile equipment, thereby improving patient safety.

Moreover, government initiatives such as awareness programs, research studies, collaborations, and product launches would drive this market growth. For instance, in January 2024, the National Single Window System (NSWS) was launched by the Drugs Controller General of India to simplify the regulatory process for medical devices. This initiative aims to create a comprehensive platform that serves as a "genuine single-window system," allowing investors to efficiently manage all necessary approvals in one place.

Also, in February 2023, the recent commentary published in The Lancet highlights significant concerns regarding the healthcare industry's heavy reliance on disposable materials. This reliance is often driven by fear and a perceived need for efficiency, rather than robust evidence supporting the superiority of disposable supplies over thoroughly sterilized reusable options.

Similarly, in May 2024, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, launched the MEDITECH STACKATHON in collaboration with the Confederation of India Industry (CII). This groundbreaking initiative aims to catalyze transformative change within India's burgeoning MedTech sector by undertaking a comprehensive value chain analysis of select medical devices.

The stackathon will focus on eight specific groups cancer therapy, imaging, critical care, assistive medical devices, body implants, surgical instruments, and hospital equipment, consumables & disposables, and IVD instruments and reagents.

Restraints

Factors such as the rise in waste generated by disposable products, insufficient reimbursement for disposable medical supplies, stringent regulatory framework, and environmental concerns, are expected to hamper the market.

Market Segment Analysis

The global disposable hospital supplies market is segmented based on product type, application, end-user, and region.

The diagnostic suppliers segment accounted for approximately 52.3% of the global disposable hospital supplies market share

The diagnostic suppliers segment is expected to hold the largest market share over the forecast period. Diagnostic supplies include various essential items for performing diagnostic tests and monitoring in healthcare environments. These supplies are vital for accurately evaluating patient health and informing treatment choices.

Diagnostic suppliers include test kits, diagnostic imaging suppliers, reagents, medical devices, and many others. Test kits are pre-assembled sets that contain all the required components for carrying out specific diagnostic tests. They can be utilized for a variety of purposes, including blood tests, urine tests, and infectious disease detection. These kits streamline the diagnostic process by providing standardized materials and clear instructions.

Moreover, key players in the industry investments and product launches & approvals that would drive this market growth. For instance, in August 2024, AmorSui, a modern personal protective equipment (PPE) brand focused on sustainability and inclusivity, announced that it had successfully raised $3.5 million in seed funding. This funding aims to support the company's mission to create PPE that is not only effective but also environmentally friendly and affordable. The medical supply industry heavily depends on disposable products and is increasingly under pressure to seek out sustainable alternatives.

Also, in January 2024, Inspira Technologies announced its intention to introduce a single-use disposable blood oxygenation kit, which is currently under development, for its INSPIRA ART medical device series. This kit is designed to be compatible with various life support machines, allowing the company to enter the disposable perfusion systems market. Launching the kit is part of Inspira's broader vision to replace traditional mechanical ventilators with advanced life support technologies.

Similarly, in September 2023, Medtronic plc announced that it had received CE Mark approval for its new all-in-one disposable Simplera continuous glucose monitor (CGM). This innovative device features a straightforward two-step insertion process and does not require overtape, making it user-friendly. The Simplera CGM is designed to work seamlessly with the InPen smart insulin pen, which offers real-time, personalized dosing guidance to simplify diabetes management.

Market Geographical Share

North America accounted for approximately 44.7% of the global disposable hospital supplies market share

North America region is expected to hold the largest market share over the forecast period owing to the growing incidence of infectious diseases, such as respiratory syncytial virus (RSV), which is a key factor driving the demand for disposable hospital supplies in North America. The rise in RSV cases, particularly in Canada, has led to an increased need for one-time-use products used in the management and prevention of these infections.

The surge in healthcare spending across North America is directly influencing the supply and availability of disposable hospital supplies. As hospitals in the region invest in expanding their services and upgrading facilities, there is a concurrent rise in the procurement of disposable items essential for providing quality patient care and maintaining strict infection control protocols. This increased investment in healthcare infrastructure is a significant factor driving the growth of the disposable hospital supplies market in North America.

Moreover, a major number of key player's presence, strategies such as partnerships and collaborations help to drive this market growth in this region. For instance, in May 2023, in the U.S., Indegene announced the expansion of its partnership with ConTIPI Medical Ltd, an innovator in non-surgical and disposable solutions for women with various pelvic floor dysfunctions. This collaboration aims to introduce a new device to the market, enhancing support for women suffering from pelvic organ prolapse (POP).

Similarly, in February 2021, Health Professional Resources (HPR), a U.S.-based supplier of medical goods and PPE, announced a manufacturing partnership with MAS Holdings, the largest apparel and textile manufacturer in South Asia. This partnership will allow HPR to launch a new line of high-performance PPE products for the healthcare industry, all manufactured by MAS Holdings has 53 manufacturing locations across 16 countries and is a long-time strategic partner to leading global brands like Nike and Victoria's Secret. The HPR line will include surgical gowns, isolation gowns, medical scrubs, reusable masks, and other PPE.

In addition, well-advanced healthcare infrastructure, key players agreements, and product approvals help to drive this market growth. For instance, in July 2022, Quipt Home Medical Corpa leading U.S. company in the home medical equipment sector specializing in comprehensive respiratory care, announced the signing of a contract with Cardinal Health at-Home, a division of Cardinal Health, Inc. (NYSE: CAH). Under this agreement, Quipt will sell disposable medical supplies while Cardinal Health will supply and distribute these products across the nation.

Also, in January 2024, BIOCORP, a subsidiary of Novo Nordisk based in France that specializes in the design and manufacturing of innovative medical devices, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SoloSmart. This smart medical device is designed to connect with SoloStar insulin pens produced by Sanofi.

Market Segmentation

By Product Type

Diagnostic Supplies

Dialysis Consumables

Radiology Consumables

Infusion Products

Incubation & Ventilation Supplies

Hypodermic Products

Sterilization Consumables

Non-woven Medical Supplies

Wound Care Consumables

Others

By Application

Cardiovascular

Cerebrovascular

Ophthalmology

Gynecology

Urology

Orthopedics

Others

By End-User

Hospitals & Specialty Clinics

Ambulatory Surgery Centers

Homecare Settings

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the disposable hospital supplies market include 3M, B. Braun SE, Cardinal Health, Abbott, BD, Medtronic, Nipro Europe Group Companies, Stryker, Johnson & Johnson Services, Inc., and Terumo Medical Corporation among others.

Key Developments

In March 2024, Hindustan Syringes and Medical Devices (HMD), a prominent producer of disposable and auto-disable syringes, introduced Dispojekt, a new single-use safety syringe aimed at minimizing needle stick injuries. A needle stick injury (NSI) refers to an accidental puncture of the skin caused by a hollow-bore needle that may contain blood or bodily fluids from another individual.

In February 2024, Argosy Healthcare Partners (AHP) completed a recapitalization and formed a partnership with Command Medical Products, a company specializing in the contract manufacturing of single-use medical devices. This strategic move aims to support the Command's growth and enhance its operational capabilities.

In March 2023, IceCure Medical Ltd. announced that the National Medical Products Administration (NMPA) of China has approved its IceSense3 disposable cryoprobes for commercial use. These cryoprobes are designed to work in conjunction with the IceSense3 console, which has already received NMPA approval. IceCure's ProSense System, marketed as IceSense3 in China, utilizes minimally invasive cryoablation technology to destroy tumors by freezing, providing an alternative to surgical removal.

In October 2023, Advanced Sterilization Products (ASP), announced a major expansion of its Sterilization Monitoring portfolio. The new products focused on Steam Monitoring will help Sterile Processing Departments (SPDs) in healthcare facilities ensure sterility more efficiently and with greater confidence in the results.

In February 2023, Asker Healthcare Group successfully acquired Dispo Medical B.V., a company that has been a key supplier and producer of medical consumables for hospitals and healthcare institutions in the Netherlands. This acquisition is part of Asker Healthcare's strategy to strengthen its offerings in the surgical sector and enhance its position in the European healthcare market.

Why Purchase the Report?

To visualize the global disposable hospital supplies market segmentation based on product type, application, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the disposable hospital supplies market with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global disposable hospital supplies market report would provide approximately 62 tables, 64 figures, and 184 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Number of Surgical Procedures
- 4.1.2. Restraints
  - 4.1.2.1. Rise in Waste Generated by Disposable Products
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Diagnostic Supplies *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Dialysis Consumables
6.4. Radiology Consumables
6.5. Infusion Products
6.6. Incubation & Ventilation Supplies
6.7. Hypodermic Products
6.8. Sterilization Consumables
6.9. Non-woven Medical Supplies
6.10. Wound Care Consumables
6.11. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Cardiovascular *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Cerebrovascular
7.4. Ophthalmology
7.5. Gynecology
7.6. Urology
7.7. Orthopedics
7.8. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals & Specialty Clinics *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgery Centers
8.4. Homecare Settings
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. 3M *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. B. Braun SE
11.3. Cardinal Health
11.4. Abbott
11.5. BD
11.6. Medtronic
11.7. Nipro Europe Group Companies
11.8. Stryker
11.9. Johnson & Johnson Services, Inc.
11.10. Terumo Medical Corporation (*LIST NOT EXHAUSTIVE)